🚀 VC round data is live in beta, check it out!
Co-Diagnostics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Co-Diagnostics and similar public comparables like Luxbright, SpectraCure, Lucyd, Redsense Medical and more.
Co-Diagnostics Overview
Founded
N/A
HQ
—
Employees
132
Website
N/A
Financials (LTM)
Market Cap
$5M
Co-Diagnostics Financials
Co-Diagnostics reported last 12-month revenue of $505K.
In the same LTM period, Co-Diagnostics generated $397K in gross profit and had net loss of ($29M).
Revenue (LTM)
Co-Diagnostics P&L
In the most recent fiscal year, Co-Diagnostics reported revenue of $4M and EBITDA of ($39M).
Co-Diagnostics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $505K | XXX | $4M | XXX | XXX | XXX |
| Gross Profit | $397K | XXX | $3M | XXX | XXX | XXX |
| Gross Margin | 79% | XXX | 75% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($39M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (989%) | XXX | XXX | XXX |
| EBIT Margin | (6205%) | XXX | (1024%) | XXX | XXX | XXX |
| Net Profit | ($29M) | XXX | ($38M) | XXX | XXX | XXX |
| Net Margin | (5823%) | XXX | (961%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Co-Diagnostics Stock Performance
Co-Diagnostics has current market cap of $5M.
Co-Diagnostics' stock price is $2.33.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $5M | 0.0% | XXX | XXX | XXX | $-17.97 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCo-Diagnostics Valuation Multiples
Co-Diagnostics trades at (10.1x) EV/Revenue multiple, and 0.1x EV/EBITDA.
Co-Diagnostics Financial Valuation Multiples
As of March 23, 2026, Co-Diagnostics has market cap of $5M.
Equity research analysts estimate Co-Diagnostics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Co-Diagnostics has a P/E ratio of (0.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5M | XXX | $5M | XXX | XXX | XXX |
| EV (current) | ($5M) | XXX | ($5M) | XXX | XXX | XXX |
| EV/Revenue | (10.1x) | XXX | (1.3x) | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBIT | 0.2x | XXX | 0.1x | XXX | XXX | XXX |
| EV/Gross Profit | (12.8x) | XXX | (1.7x) | XXX | XXX | XXX |
| P/E | (0.2x) | XXX | (0.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 0.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Co-Diagnostics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Co-Diagnostics Margins & Growth Rates
Co-Diagnostics' revenue in the last 12 month grew by 753%.
Co-Diagnostics' revenue per employee in the last FY averaged $0.0M.
Co-Diagnostics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 753% | XXX | (88%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (989%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (7%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 496% | XXX | 115% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1854% | XXX | 413% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3755% | XXX | 536% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1098% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Co-Diagnostics Public Comps
See public comps and valuation multiples for other Medical Devices and Laboratory Services comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Luxbright | XXX | XXX | XXX | XXX | XXX | XXX |
| SpectraCure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lucyd | XXX | XXX | XXX | XXX | XXX | XXX |
| Redsense Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Inventionmed | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Co-Diagnostics M&A Activity
Co-Diagnostics acquired XXX companies to date.
Last acquisition by Co-Diagnostics was on XXXXXXXX, XXXXX. Co-Diagnostics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Co-Diagnostics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCo-Diagnostics Investment Activity
Co-Diagnostics invested in XXX companies to date.
Co-Diagnostics made its latest investment on XXXXXXXX, XXXXX. Co-Diagnostics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Co-Diagnostics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Co-Diagnostics
| How many employees does Co-Diagnostics have? | As of today, Co-Diagnostics has over 132 employees. |
| Is Co-Diagnostics publicly listed? | Yes, Co-Diagnostics is a public company listed on Nasdaq. |
| What is the stock symbol of Co-Diagnostics? | Co-Diagnostics trades under CODX ticker. |
| When did Co-Diagnostics go public? | Co-Diagnostics went public in 2017. |
| Who are competitors of Co-Diagnostics? | Co-Diagnostics main competitors are Luxbright, SpectraCure, Lucyd, Redsense Medical. |
| What is the current market cap of Co-Diagnostics? | Co-Diagnostics' current market cap is $5M. |
| What is the current revenue of Co-Diagnostics? | Co-Diagnostics' last 12 months revenue is $505K. |
| What is the current revenue growth of Co-Diagnostics? | Co-Diagnostics revenue growth (NTM/LTM) is 753%. |
| What is the current EV/Revenue multiple of Co-Diagnostics? | Current revenue multiple of Co-Diagnostics is (10.1x). |
| Is Co-Diagnostics profitable? | No, Co-Diagnostics is not profitable. |
| What is the current net income of Co-Diagnostics? | Co-Diagnostics' last 12 months net income is ($29M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.